Lecture 11: Drug Discovery III Flashcards
(18 cards)
Drugs of the future
-RNA interference
-mRNA medicine
-Monoclonal antibody and antibody-drug conjugate (ADC)
-gene therapy
-CRISPR
-Stem cell (iPSC) therapy
RNA interference (ASO)
-antisense oligonucleotides (ASO)
-reduce mRNA level = less protein made
-Onpattro: RNAi therapeutic for ppl w rare/deadly genetic disorder called hereditary transthyretin-mediated amyloidosis
mRNA medicine
-introduce exogenous mRNA into body
=cells can make proteins based on introduced mRNA
-COVID19 vax
-not only vax, will be used for cancer etc
mAb and Ab-drug conjugate (ADC)
-type of y shape protein
-affect protein
-binds to target to block function
-or recognize group of cells that express target protein
-PD1 and PDL1 drugs
Gene Therapy
-virus as vehicle to deliver gene
-FDA-approved adeno-associated virus (AAV) drug Luxturna to treat rare form of inherited vision loss
CRISPR
-trial of CRISPR-Cas9 therapy (CTX001) for blood disorder B-thalassemia has been launched
-targets DNA
Stem cell (iPSCs) therapy
-most still being developed
-potential to generate any cell types in the body to replace damaged tissue
Multi-level targeting of next gen meds
-DNA: CRISPR
-RNA: mRNA and ASO
-Protein: mAbs
-Transgene: gene therapy
-Cell: stem cell tx
ASO treatment
-treat missense gain of function mutations
-not using for loss of function
Antisense oligonucleotides (ASO) mech
mRNA medicine mech
- generate mRNA seq that codes for virus spike protein (not whole virus)
- RNA seq coated in lipid for delivery (VAX)
- once injected, cells read info in the mRNA seq to produce millions of copies of spike protein
- protein frags spur immune system to produce Abs that can protect the body when real virus enters body
-must make exogenous mRNA stable
-find right coating
-COVID vax
Monoclonal Abs mech
-mAb is type of protein that very specifically binds to target
-often blocks function or tags for destruction
Antibody-drug conjugate (ADC) mech
-mAb with drug added attaches to allergen
-endocytosis of mAB-allergen into endosome
-cytosolic drugs release in lysosome
= cell death
Gene-therapy with adeno-associated virus (AAV) mech
- Transgene packed into AAV vectors
- Delivery by one time IV infusion, AAVs carrying transgene to liver
- AAV vectors deliver to nucleus of liver cells to enable production of therapeutic protein
-ex: zolgensma
Zolgensma (AAV)
-SMA is nueromuscular disorder caused by mutation in SMN1 gene
=dec in SMN protein (needed for survival of motor neurons
-Zolgensma is biologic drug consisting of AAV9 capsids that contain SMN1 transgene along w synthetic promoters
-expensive!!!
CRISPR/Cas9 editing
-Clustered Regularly Interspaced Short Palindromic Seq
-cell transfected w enzyme complex (guide molecule + healthy DNA copy + DNA-cutting enzyme)
-specially designed guide molecule finds target DNA strand
-enzyme cuts off strand
-replace w healthy copy of DNA
Stem Cell Therapy options
-induced Pluripotent Stem Cells (iPSCs) = most promising
-Embryonic stem cells (ESC)
-Neural stem cells (NSC)
-Progenitor cells
iPSC mech